Dadan, Vryll Jazzer I.
HRN: 11-80-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/04/2023
06/10/2023
IV
2.25grams
Q8hr
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes